Bonti

Developing botulinum neurotoxins for the treatment of musculoskeletal pain

placeNewport Beach, California, United States calendar_todayFounded 2015 groups10 employees language bonti.com

Innovation

10 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 292 times.

YearFilings
20186
20199
20209
20217
20225
20233
20252

Investor mix

9 investors on record; lead investors include City Hill, Viva Ventures Biotech Fund, RBV Capital; 1 has since exited.

Investor typeCountShare
Venture capital667%
Private equity111%
Angel & family office111%
Other / undisclosed111%
Coming soon